Establishing the Link Between Trial Complexity and Coordinator Capacity

Clinical Researcher—February 2020 (Volume 34, Issue 2) PEER REVIEWED Alexa Richie, DHSc; Dale Gamble, MHSc; Andrea Tavlarides, PhD; Kate Strok, CCRC, CCRA; Carol Griffin   The workforce of the clinical research enterprise continues to change and the demand for experienced professionals at the site, sponsor, and contract research organization (CRO) levels continues to increase. At […]

Interventional or Non-Interventional? Analyzing the Differences Between Clinical Studies Using Medicines in the European Union

Clinical Researcher—February 2020 (Volume 34, Issue 2) PEER REVIEWED Tiago Silva, MSc; Alexandra Parnell, MSc; Christopher Bamford, PhD; Catherine Paulen, PharmD; Simona Francisconi, MSc; Jaclyn Bosco, PhD, MPH; Louise Parmenter, PhD, MSc [Editor's Note: After Table 1, the other Tables referred to in this article may be seen in a PDF version here.]   […]

Harnessing Virtual Studies for Long-Term Follow-Up

Clinical Researcher—February 2020 (Volume 34, Issue 2) RECRUITMENT & RETENTION Henry Anhalt, DO   In the world of diabetes, researchers have discovered that diabetes drugs have cardiovascular implications. The U.S. Food and Drug Administration (FDA) wants long-term follow-up studies to ensure safety—the virtual study model is perfect for that. It was only a decade ago […]